Table 5.
Clinical, medication, and patient-reported outcomes (at time of first follow-up survey, F1) predictive of readmission within 1y (reported at 2nd follow-up survey, F2) in patients with IBD with recent hospitalization
| Risk factors | Odds ratio (95% Confidence Interval) |
|---|---|
| Clinical characteristics | |
| Patients in clinical remission | 0.52 (0.30 – 0.90) |
| Current Medications | |
| Narcotics | 0.65 (0.38 – 1.12) |
| Immunomodulator | 1.52 (0.94 – 2.46) |
| 5-ASA | 0.60 (0.36 – 0.99) |
| PROMIS Domains (per 5 points increase in PROMIS scores) | |
| Anxiety domain | 1.23 (1.00 – 1.50) |
| Depression domain | 0.80 (0.65 – 0.98) |
| Increased participation in social events domain | 0.87 (0.74 – 1.03) |
| Pain interference domain | 1.14 (0.99 – 1.31) |
Backwards logistic regression model was utilized. Variables that did not make it into the final regression model did not have an odds ratio reported: age at diagnosis, sex, body mass index, education, disease duration, history of remote hospitalization, history of prior or recent bowel surgery, biologic or corticosteroid use at time of index hospitalization, fatigue or sleep disturbance at time of index hospitalization